Genome-wide association study of coronary artery disease in the Japanese (original) (raw)

References

  1. Schunkert H, Erdmann J, Samani NJ : Genetics of myocardial infarction: a progress report. Eur Heart J 2010; 31: 918–925.
    Article Google Scholar
  2. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–978.
    Article Google Scholar
  3. Trégouët DA, König IR, Erdmann J et al: Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41: 283–285.
    Article Google Scholar
  4. Erdmann J, Grosshennig A, Braund PS et al: New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41: 280–282.
    Article CAS Google Scholar
  5. Myocardial Infarction Genetics Consortium: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009; 41: 334–341.
    Article Google Scholar
  6. Gudbjartsson DF, Bjornsdottir US, Halapi E et al: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41: 342–347.
    Article CAS Google Scholar
  7. Schunkert H, König IR, Kathiresan S et al: Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43: 333–338.
    Article CAS Google Scholar
  8. Coronary Artery Disease (C4D) Genetics Consortium: A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011; 43: 339–344.
    Article Google Scholar
  9. Soranzo N, Spector TD, Mangino M et al: A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41: 1182–1190.
    Article CAS Google Scholar
  10. Shen GQ, Li L, Rao S et al: Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008; 28: 360–365.
    Article CAS Google Scholar
  11. Saleheen D, Alexander M, Rasheed A et al: Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans. Arterioscler Thromb Vasc Biol 2010; 30: 1467–1473.
    Article CAS Google Scholar
  12. Moriyama Y, Okamura T, Inazu A et al: A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med 1998; 27: 659–667.
    Article CAS Google Scholar
  13. Okamura T : Dyslipidemia and cardiovascular disease: a series of epidemiologic studies in Japanese populations. J Epidemiol 2010; 20: 259–265.
    Article Google Scholar
  14. Skol AD, Scott LJ, Abecasis GR, Boehnke M : Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209–213.
    Article CAS Google Scholar
  15. Purcell S, Neale B, Todd-Brown K et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
    Article CAS Google Scholar
  16. Takeuchi F, Serizawa M, Yamamoto K et al: Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009; 58: 1690–1699.
    Article CAS Google Scholar
  17. Devlin B, Roeder K : Genomic control for association studies. Biometrics 1999; 55: 997–1004.
    Article CAS Google Scholar
  18. Kang HM, Sul JH, Service SK et al: Variance component model to account for sample structure in genome-wide association studies. Nat Genet 2010; 42: 348–354.
    Article CAS Google Scholar
  19. Browning BL, Browning SR : A unified approach to genotype imputation and haplotype phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet 2009; 84: 210–223.
    Article CAS Google Scholar
  20. Ozaki K, Sato H, Inoue K et al: SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet 2009; 41: 329–333.
    Article CAS Google Scholar
  21. Ozaki K, Ohnishi Y, Iida A et al: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650–654.
    Article CAS Google Scholar
  22. Ozaki K, Inoue K, Sato H et al: Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004; 429: 72–75.
    Article CAS Google Scholar
  23. Pickrell JK, Coop G, Novembre J et al: Signals of recent positive selection in a worldwide sample of human populations. Genome Res 2009; 19: 826–837.
    Article CAS Google Scholar
  24. de Bakker PI, McVean G, Sabeti PC et al: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38: 1166–1172.
    Article CAS Google Scholar
  25. Iwakawa M, Goto M, Noda S et al: DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers. Mutat Res 2005; 588: 1–6.
    Article CAS Google Scholar
  26. Takagi S, Iwai N, Yamauchi R et al: Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens Res 2002; 25: 677–681.
    Article CAS Google Scholar
  27. Kato N, Takeuchi F, Tabara Y et al: Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet 2011; 43: 531–538.
    Article CAS Google Scholar
  28. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D : Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008; 321: 1493–1495.
    Article CAS Google Scholar
  29. Li W, Xu J, Wang X et al: Lack of association between lymphotoxin-alpha, galectin-2 polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis 2010; 208: 433–436.
    Article CAS Google Scholar
  30. Zollner S, Pritchard JK : Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 2007; 80: 605–615.
    Article CAS Google Scholar
  31. Deitiker PR, Oshima M, Smith RG, Mosier DR, Atassi MZ : Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity 2006; 39: 277–288.
    Article CAS Google Scholar
  32. Björkbacka H, Lavant EH, Fredrikson GN et al: Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J Intern Med 2010; 268: 50–58.
    PubMed Google Scholar
  33. Reilly MP, Li M, He J et al: Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377: 383–392.
    Article CAS Google Scholar
  34. Hao K, Chudin E, Greenawalt D, Schadt EE : Magnitude of stratification in human populations and impacts on genome wide association studies. PLoS One 2010; 5: e8695.
    Article Google Scholar
  35. Karvanen J, Silander K, Kee F et al: The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts. Genet Epidemiol 2009; 33: 237–246.
    Article Google Scholar
  36. Ripatti S, Tikkanen E, Orho-Melander M et al: A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010; 376: 1393–1400.
    Article Google Scholar

Download references

Acknowledgements

We thank all the people who have continuously supported the Hospital-based Cohort Study at the National Center for Global Health and Medicine, the Amagasaki Study and the Kyushu University Fukuoka Cohort Study, and the KING Study. We also thank Drs Suminori Kono, Ken Sugimoto, Kei Kamide, and Chikanori Makibayashi, and the many physicians of the participating hospitals and medical institutions for their assistance in collecting the DNA samples and accompanying clinical information. This work was supported by grants for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science Technology Agency; the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation Organization (NIBIO); and KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas ‘Applied Genomics’ from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

  1. Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
    Fumihiko Takeuchi, Masato Isono & Norihiro Kato
  2. Department of Genome Science, Aichi-Gakuin University, School of Dentistry, Nagoya, Japan
    Mitsuhiro Yokota
  3. Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
    Ken Yamamoto & Hidetoshi Kitajima
  4. Division of Endocrinology and Diabetes, Department of Internal Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Eitaro Nakashima & Jiro Nakamura
  5. Department of Diabetes and Endocrinology, Chubu Rosai Hospital, Nagoya, Japan
    Eitaro Nakashima
  6. Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita, Japan
    Tomohiro Katsuya
  7. Department of Cardiology, Chiousha Iwakura Hospital, Iwakura, Japan
    Hiroyuki Asano
  8. Department of Functional Pathology, Shimane University School of Medicine, Izumo, Japan
    Toru Nabika
  9. Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan
    Takao Sugiyama
  10. Amagasaki Health Medical Foundation, Amagasaki, Japan
    Akihiro Fujioka
  11. Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan
    Nobuhisa Awata
  12. Department of Geriatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Keizo Ohnaka
  13. Department of Biotechnology, Nagoya University School of Engineering, Nagoya, Japan
    Masahiro Nakatochi
  14. Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Suita, Japan
    Hiromi Rakugi & Toshio Ogihara
  15. Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan
    Takayoshi Ohkubo & Yutaka Imai
  16. Department of Health Science, Shiga University School of Medical Science, Otsu, Japan
    Takayoshi Ohkubo
  17. Second Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan
    Kazuaki Shimamoto
  18. Mukogawa Women's University Institute for World Health Development, Nishinomiya, Japan
    Yukio Yamori
  19. Internal Medicine III, Shimane University School of Medicine, Izumo, Japan
    Shuhei Yamaguchi
  20. Shimane University Hospital, Izumo, Japan
    Shotai Kobayashi
  21. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Ryoichi Takayanagi
  22. Osaka General Medical Center, Osaka, Japan
    Toshio Ogihara

Authors

  1. Fumihiko Takeuchi
  2. Mitsuhiro Yokota
  3. Ken Yamamoto
  4. Eitaro Nakashima
  5. Tomohiro Katsuya
  6. Hiroyuki Asano
  7. Masato Isono
  8. Toru Nabika
  9. Takao Sugiyama
  10. Akihiro Fujioka
  11. Nobuhisa Awata
  12. Keizo Ohnaka
  13. Masahiro Nakatochi
  14. Hidetoshi Kitajima
  15. Hiromi Rakugi
  16. Jiro Nakamura
  17. Takayoshi Ohkubo
  18. Yutaka Imai
  19. Kazuaki Shimamoto
  20. Yukio Yamori
  21. Shuhei Yamaguchi
  22. Shotai Kobayashi
  23. Ryoichi Takayanagi
  24. Toshio Ogihara
  25. Norihiro Kato

Corresponding author

Correspondence toNorihiro Kato.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on European Journal of Human Genetics website

Supplementary information

Rights and permissions

About this article

Cite this article

Takeuchi, F., Yokota, M., Yamamoto, K. et al. Genome-wide association study of coronary artery disease in the Japanese.Eur J Hum Genet 20, 333–340 (2012). https://doi.org/10.1038/ejhg.2011.184

Download citation

Keywords